The China Securities Regulatory Commission said its Zhejiang bureau has opened an investigation into Zhejiang Sunflower Great Health Technology Co. after finding that the company’s proposed restructuring plan may contain misleading statements. The review followed market questions about the restructuring target’s actual production capacity and business model. Zhejiang Sunflower disclosed its draft restructuring plan on Sept. 22, 2025. After conducting a verification review, the Zhejiang bureau identified suspected misleading disclosure in the plan. It said the next step is to complete a full investigation and then handle the case in accordance with the law, with the stated aim of maintaining order in the mergers and acquisitions and restructuring market.
China Securities Regulatory Commission2026-01-14
China Securities Regulatory Commission opens investigation into Zhejiang Sunflower over suspected misleading statements in restructuring plan
The China Securities Regulatory Commission said its Zhejiang bureau has opened an investigation into Zhejiang Sunflower Great Health Technology Co. over suspected misleading statements in its proposed restructuring plan. The probe followed market questions about the restructuring target’s actual production capacity and business model. It will proceed with a full investigation before taking further action in accordance with the law.